Bayer at SCOPE 2027

Mar 1–4, 2027 Orlando, FL ~5k attendees Website

Bayer brings 3 presentations to SCOPE 2027 in Orlando. Its sessions cover faster clinical research, more productive clinical operations and participant-centered trials. A distinctive topic is dynamic shared ownership as a way to speed processes and raise productivity in clinical operations.

Organization	SCOPE 2027 Attendance
Bayer Leverkusen, Germany
bayer.com Large pharma German life science company with pharmaceutical, consumer health and crop science businesses.	Panel Tue Mar 2 9:15am–9:45am KEYNOTE INTERACTIVE PANEL: From Years to Months: Is Radical Acceleration in Clinical Research Finally Possible? Plenary · with Duke Clinical Research Institute, FDA, Pfizer +2 more Trial design and delivery Talk Tue Mar 2 11:05am–11:30am Faster Processes, Greater Customer Satisfaction, and Higher Productivity with Dynamic Shared Ownership in Clinical Operations Trial Design & Protocol Optimization Talk Thu Mar 4 9:25am–9:50am Giving Back, Listening Better: Building More Participant-Centered Clinical Trials Recruitment & Engagement

Organization

SCOPE 2027 Attendance

Bayer

Leverkusen, Germany

bayer.com

Large pharma

German life science company with pharmaceutical, consumer health and crop science businesses.

Panel

Tue Mar 2
9:15am–9:45am

KEYNOTE INTERACTIVE PANEL: From Years to Months: Is Radical Acceleration in Clinical Research Finally Possible?

Plenary · with Duke Clinical Research Institute, FDA, Pfizer +2 more

Trial design and delivery